GEIST:UPC Searchengine

ORD_59318/2024

DexCom, Inc. v. Abbott Logistics B.V., Abbott Laboratories GmbH, Abbott Laboratories, Abbott Oy, Abbott Scandinavia Aktiebolag, Abbott (S.A./N.V.), Abbott B.V., Abbott France (S.A.S.), Abbott GmbH, Abbott Diagnostics GmbH, Abbott Gesellschaft m.b.H., Abbott Diabetes Care Inc., Abbott s.r.l.

Date
2024-11-21
Division
Düsseldorf (DE) Local Division
Type of action
Generic Order
Language
EN

Metadata

Case IDORD_59318-2024-9629979a9311
Case number
Registry numberORD_59318/2024
Order referenceORD_59318/2024
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 4

1 Düsseldorf Local Division UPC_CFI_499/2023 Procedural Order of the Court of First Instance of the Unified Patent Court issued on 21 November 2024 concerning EP 4 026 488 CLAIMANT: DexCom, Inc., 6340 Sequen ce Drive, San Diego, California 92121, USA, represented by its CEO Kevin Sayer, represented by: Dr. Markus Grosch, Dr. Johannes Bukow, Dr. Jan Axtmann, Paul Lehmann, Quinn Emanuel Urquhart & Sullivan LLP, Moll- straße 42, 68165 Mannheim, Germany, electronic address for service: marcusgrosch@quinnemanuel.com DEFENDANTS: 1. Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064 -6400, USA, repre- sented by its board of directors which is represented by the CEO Robert Ford, 2. Abbott Diabetes Care Inc., 1360 South Loop Road, Ala-meda, California 94502, USA, repre- sented b ...